AITD1 |
|
Autoimmune thyroid disease, susceptibility to, 1
|
|
|
0.861 |
0.115 |
BLK |
P51451
|
BLK proto-oncogene, Src family tyrosine kinase
|
Kinase
|
8.3E-14 |
0.585 |
0.769 |
CD226 |
Q15762
|
CD226 molecule
|
|
3.9E-02 |
0.548 |
0.769 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCL12 |
P48061
|
C-X-C motif chemokine ligand 12
|
|
0.12 |
0.379 |
0.846 |
DICER1 |
Q9UPY3
|
dicer 1, ribonuclease III
|
Enzyme
|
1.00 |
0.446 |
0.846 |
DNASE1 |
P24855
|
deoxyribonuclease 1
|
|
7.0E-21 |
0.505 |
0.846 |
FCRL3 |
Q96P31
|
Fc receptor like 3
|
Cell adhesion
|
6.0E-21 |
0.612 |
0.769 |
FLNB |
O75369
|
filamin B
|
|
6.1E-10 |
0.458 |
0.923 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
GAD1 |
Q99259
|
glutamate decarboxylase 1
|
Enzyme
|
4.6E-02 |
0.486 |
0.885 |
HLA-DOA |
P06340
|
major histocompatibility complex, class II, DO alpha
|
Immune response
|
3.0E-10 |
0.509 |
0.808 |
HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
IL12B |
P29460
|
interleukin 12B
|
Signaling
|
1.1E-04 |
0.480 |
0.885 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
IL21 |
Q9HBE4
|
interleukin 21
|
|
0.63 |
0.441 |
0.769 |
IL21R |
Q9HBE5
|
interleukin 21 receptor
|
Receptor
|
1.00 |
0.550 |
0.731 |
IL22 |
Q9GZX6
|
interleukin 22
|
|
1.9E-04 |
0.393 |
0.885 |
IL23R |
Q5VWK5
|
interleukin 23 receptor
|
Signaling
|
5.6E-04 |
0.466 |
0.769 |